Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate AxoGen Inc before investing.

In this article, we go over a few key elements for understanding AxoGen Inc’s stock price such as:

• AxoGen Inc’s current stock price and volume
• Why AxoGen Inc’s stock price changed recently
• Upgrades and downgrades for AXGN from analysts
• AXGN’s stock price momentum as measured by its relative strength

About AxoGen Inc (AXGN)

Before we jump into AxoGen Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.

Want to learn more about AxoGen Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AxoGen Inc.

AxoGen Inc’s Stock Price as of Market Close

As of June 12, 2024, 4:00 PM, CST, AxoGen Inc’s stock price was $8.06.

AxoGen Inc is up 9.21% from its previous closing price of $7.38.

During the last market session, AxoGen Inc’s stock traded between $6.84 and $7.47. Currently, there are 43.23 million shares of AxoGen Inc stock available for purchase.

Unfortunately, AxoGen Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

AxoGen Inc Stock Price History

AxoGen Inc’s (AXGN) price is currently up 18.01% so far this month.

During the month of June, AxoGen Inc’s stock price has reached a high of $8.22 and a low of $6.57.

Over the last year, AxoGen Inc has hit prices as high as $10.83 and as low as $3.45. Year to date, AxoGen Inc’s stock is down 19.24%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AxoGen Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 11, 2024, there was 1 analyst who downgraded AxoGen Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate AxoGen Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on AxoGen Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

AxoGen Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AxoGen Inc (AXGN) by visiting AAII Stock Evaluator.

Relative Price Strength of AxoGen Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 11, 2024, AxoGen Inc has a weighted four-quarter relative price strength of -7.77%, which translates to a Momentum Score of 41 and is considered to be Average.

Want to learn more about how AxoGen Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AxoGen Inc Stock Price: Bottom Line

As of June 12, 2024, AxoGen Inc’s stock price is $8.06, which is up 9.21% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like AxoGen Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.